ClinConnect ClinConnect Logo
Search / Trial NCT03357536

Genetic Susceptibility to Listeriosis

Launched by INSTITUT PASTEUR · Nov 24, 2017

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

The clinical trial titled "Genetic Susceptibility to Listeriosis" is studying a serious foodborne infection called listeriosis, which can be particularly dangerous for older adults, pregnant women, and those with weakened immune systems. Some younger patients under 40 years old are experiencing severe forms of this illness without any known risk factors, leading researchers to suspect that genetics may play a role in why some people are more susceptible to listeriosis. The goal of the study is to find out if certain genetic traits make someone more likely to develop this infection.

To participate in this study, patients must have a confirmed case of listeriosis, especially if they are younger than 40 and don't have other health issues. Family members of those patients may also be invited to join the study, helping researchers understand the genetic links. Participants will be asked to provide consent and may undergo tests to help identify any genetic factors related to listeriosis. This study is important because it could lead to better understanding and treatment of this rare but serious infection.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for patients with Listeriosis :
  • Microbiologically documented Listeriosis (either a severe form of listeriosis, or an atypical form of listeriosis, or less than 40 years old and without any co-morbidity identified)
  • Affiliated or beneficiary of a social security system
  • Informed and written consent
  • Inclusion Criteria for volunteers related to patients with Listeriosis (after identifying a genetic susceptibility in the patient with Listeriosis) :
  • defined as father, mother, brother (s), sister (s), child (ren), grandparent (s), uncle (s), aunt (s), cousin (s), nephew (s), niece (s).
  • Affiliated or beneficiary of a social security system
  • Informed and written consent
  • Exclusion Criteria for volunteers related to patients with Listeriosis:
  • Inability to consent

About Institut Pasteur

Institut Pasteur is a renowned global research organization dedicated to advancing biomedical science and public health. Established in 1887, it has a rich history of groundbreaking contributions to the understanding and prevention of infectious diseases. The institute conducts innovative clinical trials aimed at developing vaccines, diagnostics, and therapeutic strategies to combat a wide range of health threats. With a multidisciplinary approach and a commitment to collaboration, Institut Pasteur plays a pivotal role in translating scientific discoveries into tangible health solutions, thereby enhancing global health security and improving patient outcomes.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Marc Lecuit

Study Director

Institut Pasteur

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials